SCHEMBL6589376

SCHEMBL6589376

COc1cc2c(cc1OC)CN(C(=O)C1CCCN(CCC(=O)Nc3ccc4c(c3)OCO4)C1)CC2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
TSHR P16473 2/20 0.53
KMT2A Q03164 2/20 0.53
GAA P10253 1/20 0.53
ABCB1 P08183 2/20 0.53
TP53 P04637 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 4/20 0.52
POLB P06746 2/20 0.50
MEN1 O00255 1/20 0.47
KDM4E B2RXH2 3/20 0.47
TDP1 Q9NUW8 1/20 0.46
LMNA P02545 1/20 0.46
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6588710 1.00 MAPT (0.61) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6591085 0.99 CYP1A2 (0.60) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Fumaric Acid SCHEMBL6588822 0.96 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Fumaric Acid SCHEMBL6588817 0.96 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Cadaverine Tartrate SCHEMBL6589585 0.95 MAPT (0.55) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Cadaverine Tartrate SCHEMBL6590121 0.95 MAPT (0.55) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Oxalic Acid SCHEMBL6595339 0.95 MAPT (0.58) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Oxalic Acid SCHEMBL6589408 0.91 CYP1A2 (0.68) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6589249 0.89 ALDH1A1 (0.54) KMT2AABCB1ALDH1A1POLBMEN1
Hydrochloric Acid SCHEMBL6586761 0.86 ALDH1A1 (0.52) MAPTTSHRKMT2ATP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1186601-B1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMA CO LTD (JP) 2004-03-24 EP claimed
US-6573279-B1 Drug, particularly to a novel isoquinoline derivative or its salt having an If current inhibitory effect without serious side effects such as convulsion and also to a drug, particularly a cardiac rate lowering agent, containing the ASTELLAS PHARMA INC. (JP) 2003-06-03 US claimed
EP-1186601-A1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2002-03-13 EP claimed